Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Ivabradine on Left Ventricular Reverse Remodeling in Nonischemic Dilated Cardiomyopathy (NIDCM) on Current Medical Therapy Era

NCT05973591 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT05973591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05973591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Ivabradine on Left Ventricular Reverse Remodeling in Nonischemic Dilated Cardiomyopathy (NIDCM) on Current Medical Therapy Era
Lead sponsor
Yonsei University
Phase
Observational
Overall status
Unknown status
Start date
July 15, 2023
Completion date
December 31, 2024
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dilated cardiomyopathy, heart failure, reduced ejection fraction, ventricular remodeling